News | Breast Imaging | May 30, 2017

Mozart intraoperative specimen imaging system gives breast surgeons superior view of surgical margins

Kubtec Granted Additional Patent for Breast Specimen Imaging Using 3-D Tomosynthesis

May 30, 2017 — Kubtec announced recently that the U.S. Patent Office has granted the company an additional patent for its technology used for breast specimen imaging using 3-D tomosynthesis.

The patent, Specimen Radiography with Tomosynthesis in a Cabinet (Patent Number 9,642,581 B2) was issued on May 9, 2017 and refers to technology currently embodied in the Kubtec Mozart System. The company calls it the only intraoperative specimen imaging system to use 3-D tomosynthesis to give breast surgeons a superior view of their surgical margins. A recent study has demonstrated that the use of this technology enables significant reductions in surgical re-excision rates when compared to the more traditional 2-D planar imaging.

For more information: www.kubtec.com


Related Content

News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
Subscribe Now